Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners

Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…

VKTX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.70%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $81,779,033.02

Viking Therapeutics Insider Trading History Chart

Viking Therapeutics Share Price & Price History

^$53.57

▼ -1.49 (-2.71%)

As of 11/14/2024 05:45 PM ET

Days: 30 | 90 | 365

Trump’s Sending THIS Crypto Higher on Purpose

From Crypto 101 Media | Ad

Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin…

YES, I WANT THE #1 CRYPTO NOW

Viking Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/8/2024	Lawson Macartney	Director	Sell	2,000	$68.67	$137,340.00	47,965
10/28/2024	Greg Zante	CFO	Sell	131,687	$76.61	$10,088,541.07	149,366
10/25/2024	Sarah Kathryn Rouan	Director	Sell	11,000	$80.89	$889,790.00	9,500
9/20/2024	Brian Lian	CEO	Sell	216,130	$70.83	$15,308,487.90	2,304,927
9/20/2024	J. Matthew Singleton	Director	Sell	10,300	$69.50	$715,850.00	9,500
8/21/2024	Brian Lian	CEO	Sell	1,000	$69.90	$69,900.00	2,354,927
8/21/2024	J. Matthew Singleton	Director	Sell	5,700	$69.72	$397,404.00	9,500
8/19/2024	Brian Lian	CEO	Sell	112,870	$65.80	$7,426,846.00	2,354,927
8/19/2024	J. Matthew Singleton	Director	Sell	16,000	$62.22	$995,520.00	9,500
8/14/2024	J. Matthew Singleton	Director	Sell	20,786	$57.53	$1,195,818.58	9,500
7/30/2024	Brian Lian	CEO	Sell	115,859	$57.58	$6,671,161.22	2,354,927
7/30/2024	Marianna Mancini	COO	Sell	18,026	$57.13	$1,029,825.38	362,149
5/3/2024	Greg Zante	CFO	Sell	66,756	$74.69	$4,986,005.64	174,854
5/1/2024	Marianna Mancini	COO	Sell	281,425	$78.66	$22,136,890.50	348,508
2/8/2024	Brian Lian	CEO	Sell	269,079	$26.87	$7,230,152.73	2,184,882
2/8/2024	Sarah Kathryn Rouan	Director	Sell	25,000	$28.05	$701,250.00
1/30/2024	Brian Lian	CEO	Sell	35,000	$23.95	$838,250.00	2,264,882
1/19/2024	Sarah Kathryn Rouan	Director	Sell	30,000	$23.05	$691,500.00
1/4/2024	Greg Zante	CFO	Sell	15,000	$17.90	$268,500.00	180,730
5/16/2023	Charles A. Rowland, Jr.	Director	Sell	40,000	$25.00	$1,000,000.00	30,000
5/1/2023	Brian Lian	CEO	Sell	45,000	$22.45	$1,010,250.00	2,197,963
4/24/2023	Lawson Macartney	Director	Sell	16,000	$22.00	$352,000.00	47,965
4/19/2023	Brian Lian	CEO	Sell	35,000	$21.45	$750,750.00	2,242,963
4/17/2023	Brian Lian	CEO	Sell	155,000	$20.45	$3,169,750.00	2,277,963
4/17/2023	Greg Zante	CFO	Sell	7,500	$20.00	$150,000.00	149,279
4/17/2023	Lawson Macartney	Director	Sell	20,786	$20.00	$415,720.00	47,965
4/17/2023	Marianna Mancini	COO	Sell	12,500	$20.00	$250,000.00	287,763
4/13/2023	Brian Lian	CEO	Sell	79,336	$18.45	$1,463,749.20	2,307,963
4/11/2023	Greg Zante	CFO	Sell	56,295	$18.00	$1,013,310.00	149,279
4/3/2023	Brian Lian	CEO	Sell	22,000	$17.85	$392,700.00	2,232,963
4/3/2023	Greg Zante	CFO	Sell	30,911	$18.00	$556,398.00	147,778
3/31/2023	Brian Lian	CEO	Sell	67,970	$17.45	$1,186,076.50	2,254,963
3/30/2023	Greg Zante	CFO	Sell	131,029	$17.00	$2,227,493.00	147,778
3/29/2023	Marianna Mancini	COO	Sell	41,242	$16.00	$659,872.00	261,895

Trump’s Back, but DC’s Coming for Your Money!

From Genesis Gold Group | Ad

Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy with a heavy hand—building up infrastructure, slapping tariffs on imports, and going all-in on U.S. jobs. But here's the kicker: while Trump's focused on making America stronger, the Washington elite is ready to fight back…

Get ahead of the game with 3 proven strategies to protect your retirement from Washington's next mov

SEC Filings (Institutional Ownership Changes) for Viking Therapeutics (NASDAQ:VKTX)

76.03% of Viking Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Viking Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/14/2024	Rockefeller Capital Management L.P.	34,023	$2.15M	0.0%	+109.1%	0.031%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	472,244	$29.90M	0.0%	-1.5%	0.424%
11/14/2024	Financial Counselors Inc.	45,981	$2.91M	0.0%	N/A	0.041%
11/14/2024	Zurcher Kantonalbank Zurich Cantonalbank	22,823	$1.45M	0.0%	+2.9%	0.020%
11/14/2024	Stone House Investment Management LLC	500	$32K	0.0%	+66.7%	0.000%
11/13/2024	BNP Paribas Financial Markets	86,712	$5.49M	0.0%	-66.2%	0.078%
11/13/2024	D.A. Davidson & CO.	3,844	$0.24M	0.0%	N/A	0.003%
11/13/2024	FMR LLC	16,619,430	$1.05B	0.1%	+0.5%	14.913%
11/13/2024	The Manufacturers Life Insurance Company	24,630	$1.56M	0.0%	+20.3%	0.022%
11/13/2024	Bank of Montreal Can	35,252	$2.17M	0.0%	+548.8%	0.032%
11/13/2024	Mirabella Financial Services LLP	7,839	$0.50M	0.0%	+21.6%	0.007%
11/13/2024	Independent Advisor Alliance	5,050	$0.32M	0.0%	+19.6%	0.005%
11/12/2024	Westfield Capital Management Co. LP	930,370	$58.90M	0.3%	+18.3%	0.835%
11/12/2024	Crewe Advisors LLC	16,366	$1.04M	0.1%	N/A	0.015%
11/12/2024	Algert Global LLC	31,264	$1.98M	0.1%	-6.8%	0.028%
11/12/2024	Cerity Partners LLC	13,969	$0.88M	0.0%	N/A	0.013%
11/12/2024	Citigroup Inc.	129,345	$8.19M	0.0%	+13.7%	0.116%
11/12/2024	Raymond James Trust N.A.	4,410	$0.28M	0.0%	N/A	0.004%
11/12/2024	Charles Schwab Investment Management Inc.	715,597	$45.30M	0.0%	+6.6%	0.642%
11/12/2024	Activest Wealth Management	1,745	$0.11M	0.0%	+40.2%	0.002%
11/12/2024	Massachusetts Financial Services Co. MA	248,269	$15.72M	0.0%	+4.9%	0.223%
11/8/2024	JW Asset Management LLC	45,000	$2.85M	1.3%	N/A	0.040%
11/8/2024	Connor Clark & Lunn Investment Management Ltd.	158,349	$10.03M	0.0%	+218.2%	0.142%
11/8/2024	Avior Wealth Management LLC	3,172	$0.20M	0.0%	+39.1%	0.003%
11/8/2024	Prospera Financial Services Inc	4,707	$0.30M	0.0%	N/A	0.004%
11/7/2024	Meeder Asset Management Inc.	1,958	$0.12M	0.0%	+144.1%	0.002%
11/7/2024	Quest Partners LLC	1,080	$68K	0.0%	-14.1%	0.001%
11/7/2024	Swiss National Bank	193,800	$12.27M	0.0%	+0.1%	0.174%
11/7/2024	Thrivent Financial for Lutherans	28,251	$1.79M	0.0%	+2.7%	0.025%
11/6/2024	LJI Wealth Management LLC	18,400	$1.17M	0.2%	-39.1%	0.017%
11/6/2024	Royce & Associates LP	13,334	$0.84M	0.0%	N/A	0.012%
11/6/2024	OneDigital Investment Advisors LLC	3,260	$0.21M	0.0%	N/A	0.003%
11/6/2024	Curi RMB Capital LLC	6,034	$0.38M	0.0%	N/A	0.005%
11/6/2024	KBC Group NV	2,997	$0.19M	0.0%	+18.7%	0.003%
11/6/2024	Oppenheimer & Co. Inc.	102,324	$6.48M	0.1%	+43.5%	0.092%
11/5/2024	Victory Capital Management Inc.	19,308	$1.22M	0.0%	-33.2%	0.017%
11/5/2024	Aptus Capital Advisors LLC	38,143	$2.42M	0.0%	+34.1%	0.034%
11/5/2024	Prime Capital Investment Advisors LLC	3,719	$0.24M	0.0%	N/A	0.003%
11/5/2024	Verus Capital Partners LLC	3,510	$0.22M	0.0%	N/A	0.003%
11/5/2024	Platform Technology Partners	4,560	$0.29M	0.1%	N/A	0.004%
11/5/2024	GSA Capital Partners LLP	8,160	$0.52M	0.0%	+64.6%	0.007%
11/4/2024	Venturi Wealth Management LLC	3,100	$0.20M	0.0%	N/A	0.003%
11/4/2024	Lisanti Capital Growth LLC	46,865	$2.97M	0.8%	+15.4%	0.042%
11/4/2024	Chartwell Investment Partners LLC	36,666	$2.32M	0.1%	+88.0%	0.033%
11/4/2024	Los Angeles Capital Management LLC	10,948	$0.69M	0.0%	-10.8%	0.010%
11/4/2024	Sigma Planning Corp	15,119	$0.96M	0.0%	N/A	0.014%
11/1/2024	Assetmark Inc.	10,489	$0.66M	0.0%	+712.5%	0.009%
11/1/2024	Cahill Wealth Management LLC	13,780	$0.87M	0.5%	+9.5%	0.012%
11/1/2024	Fiera Capital Corp	291,318	$18.44M	0.1%	N/A	0.261%
11/1/2024	Quantum Private Wealth LLC	84,084	$5.32M	1.8%	+9.3%	0.075%
11/1/2024	Lewis Asset Management LLC	30,395	$1.92M	1.4%	+14.9%	0.028%
10/31/2024	Keudell Morrison Wealth Management	4,306	$0.27M	0.1%	+5.9%	0.004%
10/31/2024	Principal Financial Group Inc.	593,528	$37.58M	0.0%	+29.9%	0.538%
10/30/2024	Cornerstone Capital Inc.	29,770	$1.89M	0.2%	-12.3%	0.027%
10/30/2024	AlphaCentric Advisors LLC	3,500	$0.22M	0.2%	-78.8%	0.003%
10/30/2024	Wetzel Investment Advisors Inc.	3,500	$0.22M	0.1%	+12.9%	0.003%
10/29/2024	Nvwm LLC	15,784	$1M	0.3%	N/A	0.014%
10/29/2024	Emerald Advisers LLC	339,047	$21.47M	0.8%	+3.7%	0.307%
10/29/2024	Van ECK Associates Corp	9,436	$0.57M	0.0%	-42.0%	0.009%
10/29/2024	Harbor Capital Advisors Inc.	139,252	$8.82M	0.4%	+119.5%	0.126%
10/29/2024	Janney Montgomery Scott LLC	20,985	$1.33M	0.0%	-14.7%	0.019%
10/29/2024	Emerald Mutual Fund Advisers Trust	244,526	$15.48M	0.8%	+0.9%	0.222%
10/29/2024	Janney Capital Management LLC	3,457	$0.22M	0.0%	N/A	0.003%
10/29/2024	Private Wealth Partners LLC	6,240	$0.40M	0.0%	+24.8%	0.006%
10/29/2024	F M Investments LLC	47,754	$3.02M	0.1%	+17.0%	0.043%
10/28/2024	Focus Financial Network Inc.	5,154	$0.33M	0.0%	-9.4%	0.005%
10/28/2024	Oak Ridge Investments LLC	13,222	$0.84M	0.1%	N/A	0.012%
10/28/2024	US Bancorp DE	3,812	$0.24M	0.0%	-24.0%	0.003%
10/25/2024	Farmers & Merchants Investments Inc.	13,650	$0.86M	0.0%	+3.0%	0.012%
10/25/2024	Pallas Capital Advisors LLC	21,405	$1.36M	0.1%	+10.7%	0.019%
10/24/2024	Nisa Investment Advisors LLC	50,073	$3.17M	0.0%	+5,482.3%	0.045%
10/24/2024	J.W. Cole Advisors Inc.	4,896	$0.31M	0.0%	N/A	0.004%
10/24/2024	PFG Investments LLC	3,640	$0.23M	0.0%	N/A	0.003%
10/23/2024	Values First Advisors Inc.	884	$56K	0.0%	N/A	0.001%
10/22/2024	International Assets Investment Management LLC	1,004,033	$63.57M	0.0%	+10,775.6%	0.911%
10/22/2024	Private Advisor Group LLC	9,086	$0.58M	0.0%	+66.4%	0.008%
10/22/2024	Signaturefd LLC	1,351	$86K	0.0%	+16.2%	0.001%
10/21/2024	Foundations Investment Advisors LLC	3,445	$0.22M	0.0%	N/A	0.003%
10/21/2024	Gilliland Jeter Wealth Management LLC	510	$32K	0.0%	N/A	0.000%
10/19/2024	Allspring Global Investments Holdings LLC	605	$38K	0.0%	-83.5%	0.001%
10/19/2024	Nepsis Inc.	177,714	$11.25M	2.7%	N/A	0.161%
10/19/2024	CNB Bank	773	$49K	0.0%	N/A	0.001%
10/18/2024	Raymond James & Associates	441,590	$27.96M	0.0%	+43.2%	0.400%
10/18/2024	Blue Trust Inc.	407	$26K	0.0%	N/A	0.000%
10/16/2024	Vontobel Holding Ltd.	6,059	$0.38M	0.0%	+17.8%	0.005%
10/16/2024	SeaCrest Wealth Management LLC	7,190	$0.46M	0.0%	+8.8%	0.007%
10/11/2024	Creative Planning	16,955	$1.07M	0.0%	+7.6%	0.015%
10/10/2024	Exchange Traded Concepts LLC	69,503	$4.40M	0.1%	+320.3%	0.063%
10/9/2024	Profit Investment Management LLC	68,001	$4.31M	3.4%	-32.2%	0.062%
10/9/2024	Sanders Morris Harris LLC	5,000	$0.32M	0.1%	N/A	0.005%
10/9/2024	Perpetual Ltd	1,269,152	$80.35M	0.9%	+55.4%	1.151%
10/8/2024	CWM LLC	2,036	$0.13M	0.0%	+34.1%	0.002%
10/7/2024	GAMMA Investing LLC	438	$28K	0.0%	+124.6%	0.000%
10/5/2024	Handelsbanken Fonder AB	180,000	$11.40M	0.0%	+721.9%	0.163%
10/3/2024	SG Americas Securities LLC	8,503	$0.54M	0.0%	-90.5%	0.008%
10/2/2024	Massmutual Trust Co. FSB ADV	553	$35K	0.0%	+84.3%	0.001%
9/5/2024	Sanctuary Advisors LLC	3,580	$0.19M	0.0%	N/A	0.003%
8/30/2024	Gordian Capital Singapore Pte Ltd	800	$42K	0.0%	-75.8%	0.001%
8/27/2024	Clearbridge Investments LLC	584,601	$30.99M	0.0%	-2.1%	0.530%
8/27/2024	Dana Investment Advisors Inc.	9,943	$0.53M	0.0%	+242.7%	0.009%

Data available starting January 2016

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It also develops VK5211, an orally available non-steroidal selective androgen receptor modulator that is in Phase II clinical trials for the treatment of patients recovering from non-elective hip fracture surgery; VK0612, an orally available Phase IIb-ready drug candidate for type 2 diabetes; VK2735, a novel dual agonist of the glucagon-like peptide, which is in Phase 1 SAD/MAD clinical trial, and VK0214, an orally available tissue and receptor-subtype selective agonist of the TRß for X-linked adrenoleukodystrophy. The company was incorporated in 2012 and is headquartered in San Diego, California.

Today's Range

Now: $53.57

$53.56

$56.00

50 Day Range

MA: $64.72

$54.13

$78.03

52 Week Range

Now: $53.57

$10.34

$99.41

Volume

3,790,739 shs

Average Volume

4,530,367 shs

Market Capitalization

$5.97 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

Who are the company insiders with the largest holdings of Viking Therapeutics?: Viking Therapeutics' top insider shareholders include:
Brian Lian (CEO)
Marianna Mancini (COO)
Greg Zante (CFO)
Lawson Macartney (Director)
Charles A Rowland Jr (Director)
J Matthew Singleton (Director)
Sarah Kathryn Rouan (Director)
Learn More about top insider investors at Viking Therapeutics.
Who are the major institutional investors of Viking Therapeutics?: Viking Therapeutics' top institutional investors include:
FMR LLC — 14.91%
Perpetual Ltd — 1.15%
International Assets Investment Management LLC — 0.91%
Westfield Capital Management Co. LP — 0.83%
Charles Schwab Investment Management Inc. — 0.64%
Principal Financial Group Inc. — 0.54%
Learn More about top institutional investors of Viking Therapeutics stock.
Which major investors are selling Viking Therapeutics stock?: In the previous quarter, VKTX stock was sold by these institutional investors:
BNP Paribas Financial Markets
SG Americas Securities LLC
Profit Investment Management LLC
AlphaCentric Advisors LLC
LJI Wealth Management LLC
Victory Capital Management Inc.
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Van ECK Associates Corp
Within the last year, company insiders that have sold Viking Therapeutics company stock include:
Brian Lian (CEO)
Marianna Mancini (COO)
Greg Zante (CFO)
Lawson Macartney (Director)
Charles A Rowland Jr (Director)
J Matthew Singleton (Director)
Learn More investors selling Viking Therapeutics stock.
Which major investors are buying Viking Therapeutics stock?: Within the previous quarter, VKTX stock was purchased by institutional investors including:
International Assets Investment Management LLC
Perpetual Ltd
Fiera Capital Corp
Nepsis Inc.
Handelsbanken Fonder AB
Westfield Capital Management Co. LP
Principal Financial Group Inc.
Raymond James & Associates